✦ LIBER ✦

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: Results of a randomized, double-blind, phase 2, parallel-arm study

✍ Scribed by Tew, William P.; Colombo, Nicoletta; Ray-Coquard, Isabelle; del Campo, Josep M.; Oza, Amit; Pereira, Deolinda; Mammoliti, Serafina; Matei, Daniela; Scambia, Giovanni; Tonkin, Katia; Shun, Zhenming; Sternas, Lars; Spriggs, David R.

Book ID: 121653700
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 154 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28406

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous aflibercept for treatment of

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

✍ Walter H Gotlieb; Frederic Amant; Suresh Advani; Chanchal Goswami; Hal Hirte; Di 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 196 KB

Second-Line Treatment with Intravenous G

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB

519 POSTER A phase 2, single-arm study o

519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer

✍ C.M. Matthews; S.N. Ho; M. Barve; K.M. Bell-McGuinn; L. Gilbert; R.T. Penson; E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Trial in progress: A randomized double-b

Trial in progress: A randomized double-blind phase 3 trial comparing vintafolide+pegylated liposomal doxorubicin (PLD) versus PLD+placebo in patients with platinum-resistant ovarian cancer (PROCEED)

✍ Naumann, R.W.; Gilbert, L.; Habbe, A.; Ma, H.; Ghamande, S.; Vergote, I.B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Vandetanib Versus Gefitinib in Patients

Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

✍ Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B. G.; Rizvi, N. A.; Capo, A. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 210 KB

A phase II, single-arm study of the anti

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

✍ Katherine M. Bell-McGuinn; Carolyn M. Matthews; Steffan N. Ho; Minal Barve; Lucy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB